Kumamoto, Japan

Ryoichi Kitano

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Km Biologics Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryoichi Kitano. Retrieved from https://idiyas.com/inventor/ryoichi-kitano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryoichi Kitano: Innovator in Vaccine Development

Introduction

Ryoichi Kitano is a prominent inventor based in Kumamoto, Japan. He has made significant contributions to the field of vaccine development, particularly through his innovative work on virus-like particles.

Latest Patents

One of Ryoichi Kitano's notable patents is a vaccine containing virus-like particles. This invention provides a vaccine that includes virus-like particles derived from virus particles with an envelope. The unique aspect of this vaccine is that the lipid-component content of the virus-like particles is reduced compared to that of the original virus particles. This innovation has the potential to enhance vaccine efficacy and safety.

Career Highlights

Ryoichi Kitano is associated with Km Biologics Co., Ltd., where he continues to advance research in the field of biotechnology. His work has been instrumental in developing new approaches to vaccine formulation and delivery.

Collaborations

Throughout his career, Ryoichi Kitano has collaborated with esteemed colleagues, including Kazuhiko Kimachi and Motoharu Abe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ryoichi Kitano's contributions to vaccine development through his innovative patent demonstrate his commitment to advancing public health. His work continues to inspire future research in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…